| Literature DB >> 23381024 |
Soek Sin Teh1, Gwendoline Cheng Lian Ee, Siau Hui Mah, Yang Mooi Lim, Zuraini Ahmad.
Abstract
The cytotoxic structure-activity relationships among a series of xanthone derivatives from Mesua beccariana, Mesua ferrea and Mesua congestiflora were studied. Eleven xanthone derivatives identified as mesuarianone (1), mesuasinone (2), mesuaferrin A (3), mesuaferrin B (4), mesuaferrin C (5), 6-deoxyjacareubin (6), caloxanthone C (7), macluraxanthone (8), 1,5-dihydroxyxanthone (9), tovopyrifolin C (10) and α-mangostin (11) were isolated from the three Mesua species. The human cancer cell lines tested were Raji, SNU-1, K562, LS-174T, SK-MEL-28, IMR-32, HeLa, Hep G2 and NCI-H23. Mesuaferrin A (3), macluraxanthone (8) and α-mangostin (11) showed strong cytotoxicities as they possess significant inhibitory effects against all the cell lines. The structure-activity relationship (SAR) study revealed that the diprenyl, dipyrano and prenylated pyrano substituent groups of the xanthone derivatives contributed towards the cytotoxicities.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23381024 PMCID: PMC6270040 DOI: 10.3390/molecules18021985
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1–11.
Xanthone derivatives from M. beccariana, M. ferrea and M. congestiflora.
| Compds. | R2 | R3 | R4 | R5 | R6 | R7 | R8 |
|---|---|---|---|---|---|---|---|
| H | OH | H | |||||
| geranyl | H | OH | H | H | |||
| prenyl B | OH | OH | H | H | |||
| H | OH | H | |||||
| H | H | prenyl A | OH | OCH3 | |||
| H | OH | H | H | H | |||
| prenyl B | OH | H | H | H | |||
| prenyl B | OH | OH | H | H | |||
| H | H | H | OH | H | H | H | |
| OCH3 | OH | H | OH | H | H | H | |
| prenyl A | OH | H | OH | H | OCH3 | prenyl A | |
prenyl A: ; prenyl B: ; geranyl: .
IC50 values of a Panel of Human Cancer Cell Lines Treated with Pure Compounds from the three Mesua species.
| Compds. | Cell Lines with IC50 values (µM) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Raji | SNU-1 | K562 | LS-174T | SK-MEL-28 | IMR-32 | HeLa | Hep G2 | NCI-H23 | |
| 25.46 ± 0.90 | 23.78 ± 1.33 | 14.93 ± 0.29 | - | - | - | 49.83 ± 1.31 | - | - | |
| 5.61 ± 2.25 | 26.61 ± 0.58 | 7.02 ± 0.50 | 91.19 ± 1.45 | - | - | 6.12 ± 1.82 | - | - | |
| 1.78 ± 0.57 | 3.17 ± 1.05 | 2.54 ± 2.00 | 1.17 ± 2.02 | 0.36 ± 2.38 | 0.79 ± 1.24 | 2.39 ± 1.07 | 3.68 ± 2.41 | 2.64 ± 2.95 | |
| 37.24 ± 0.72 | 1.19 ± 1.36 | 13.95 ± 0.72 | 9.31 ± 2.36 | 1.48 ± 1.24 | - | 18.60 ± 1.52 | 2.32 ± 1.07 | 8.98 ± 1.32 | |
| 41.90 ± 1.51 | 50.80 ± 1.50 | 45.73 ± 1.39 | - | 81.29 ± 2.30 | 91.46 ± 1.45 | - | 91.46 ± 1.04 | 92.68 ± 1.25 | |
| 53.77 ± 1.11 | 41.29 ± 1.36 | 60.65 ± 0.64 | - | 88.71 ± 2.19 | - | 60.48 ± 1.59 | - | 60.48 ± 1.87 | |
| 15.50 ± 1.99 | 24.79 ± 1.96 | 18.20 ± 1.32 | 28.94 ± 2.20 | - | 18.60 ± 1.03 | 6.88 ± 1.54 | 6.22 ± 1.49 | 15.42 ± 2.88 | |
| 2.18 ± 1.87 | 5.08 ± 2.20 | 18.25 ± 1.25 | 9.90 ± 2.47 | 1.40 ± 1.69 | 2.49 ± 0.54 | 5.28 ± 2.04 | 4.24 ± 2.13 | 1.85 ± 1.76 | |
| - | 95.53 ± 1.81 | - | - | - | - | 37.68 ± 2.53 | - | - | |
| - | - | - | - | - | - | - | - | - | |
| 6.10 ± 1.20 | 8.90 ± 1.06 | 6.34 ± 2.24 | 10.17 ± 1.68 | 8.88 ± 1.77 | 11.44 ± 2.45 | 10.49 ± 2.05 | 13.90 ± 1.24 | 10.00 ± 0.53 | |
| 6.89 ± 0.80 | 20.86 ± 1.93 | 32.75 ± 3.20 | - | 72.45 ± 2.07 | - | 26.49 ± 1.74 | 17.25 ± 1.85 | 57.95 ± 1.88 | |
IC50 values less than 10 µM indicates strong activity; 10 µM < IC50 values < 50 µM indicates moderate activity; (-): IC50 values more than 50 µM indicates weak activity. Each data represents the mean of three independent experiments; Q represents Quercetin.
Figure 2IC50 values of Compounds 1–11 and quercetin against (A) Raji and K562 cells, (B) SNU-1, Hep G2 and NCI-H23 cells, (C) LS-174T, SK-MEL-28 and IMR-32 cells and (D) HeLa cells.